GLOBAL - Global index group FTSE has launched a new index, the FTSE techMARK mediscience, designed to reflect the market performance of growth companies listed on the London Stock Exchange's (LSE) new market, techMARK mediscience.
The new index will begin calculation today. FTSE techMARK mediscience will provide investors in small and mid-sized companies from the healthcare industry with the a measurement tool of the new medical market. The new index forms part of the FTSE techMARK Index Series, and will be reviewed quarterly, by an independent committee of market users.
Commenting on the techMARK mediscience market, Martin Wheatley, deputy CEO of LSE, said “The mediscience industry attracts a lot of interest – from issuers, investors, intermediaries and the media alike.
“By providing focus, techMARK mediscience will draw liquidity to this new market and make investment decisions easier.”
By Janet Du Chenne
Thousands of savers taking tax-free lump sums ahead of retirement are at risk of a pensions shortfall in later life due to neglecting their remaining pot, Zurich has warned.
Professional Pensions is looking to update its list of pensions master trusts in the UK ahead of authorisation. Can you help?
Headline dividend payments have reached record levels in 2018. James Phillips asks if trustees should be concerned over the current high level of yields.